NO20042502L - Farmasoytisk formulering omfattende bicalutamid - Google Patents

Farmasoytisk formulering omfattende bicalutamid

Info

Publication number: NO20042502L
Authority: NO; Norway
Prior art keywords: bicalutamide; pharmaceutical formulation; formulation; pharmaceutical
Prior art date: 2001-11-16

Application number

NO20042502A

Other languages

English (en)

Norwegian (no)

Inventor

Ian Derke Cockshott

Julie Kay Cahill

Nicola Frances Bateman

Neill Hugh Carman

Original Assignee

Astrazeneca Uk Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-11-16

Filing date

2004-06-15

Publication date

2004-08-09

2004-06-15 Application filed by Astrazeneca Uk Ltd filed Critical Astrazeneca Uk Ltd

2004-08-09 Publication of NO20042502L publication Critical patent/NO20042502L/no

Links

LKJPYSCBVHEWIU-KRWDZBQOSA-N (R)-bicalutamide Chemical compound C([C@@](O)(C)C(=O)NC=1C=C(C(C#N)=CC=1)C(F)(F)F)S(=O)(=O)C1=CC=C(F)C=C1 LKJPYSCBVHEWIU-KRWDZBQOSA-N 0.000 title 1
229960000997 bicalutamide Drugs 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Nutrition Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Physiology (AREA)
Engineering & Computer Science (AREA)
Urology & Nephrology (AREA)
Bioinformatics & Cheminformatics (AREA)
Inorganic Chemistry (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20042502A 2001-11-16 2004-06-15 Farmasoytisk formulering omfattende bicalutamid NO20042502L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE0103839A SE0103839D0 (sv)	2001-11-16	2001-11-16	Pharmaceutical formulation & product
PCT/GB2002/005159 WO2003043606A1 (en)	2001-11-16	2002-11-14	Pharmaceutical formulation comprising bicalutamide

Publications (1)

Publication Number	Publication Date
NO20042502L true NO20042502L (no)	2004-08-09

Family

ID=20286023

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20042502A NO20042502L (no)	2001-11-16	2004-06-15	Farmasoytisk formulering omfattende bicalutamid

Country Status (20)

Country	Link
US (1)	US20050038111A1 (de)
EP (1)	EP1448168B1 (de)
JP (1)	JP2005514355A (de)
KR (1)	KR20050044468A (de)
CN (1)	CN1615122A (de)
AR (1)	AR037390A1 (de)
AT (1)	ATE350016T1 (de)
AU (1)	AU2002343024A1 (de)
BR (1)	BR0214135A (de)
CA (1)	CA2466986A1 (de)
DE (1)	DE60217390T2 (de)
ES (1)	ES2278063T3 (de)
IL (1)	IL161902A0 (de)
MX (1)	MXPA04004591A (de)
NO (1)	NO20042502L (de)
SE (1)	SE0103839D0 (de)
TW (1)	TW200406200A (de)
UY (1)	UY27539A1 (de)
WO (1)	WO2003043606A1 (de)
ZA (1)	ZA200403689B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE307571T1 (de) *	2001-02-27	2005-11-15		Pharmazeutische formulierung enthaltend bicalutamid
US7524866B2 (en)	2001-11-29	2009-04-28	Gtx, Inc.	Prevention and treatment of androgen—deprivation induced osteoporosis
US7332525B2 (en)	2003-01-17	2008-02-19	Castle Erik P	Method of treatment of prostate cancer and composition for treatment thereof
US7226622B2 (en)	2003-09-18	2007-06-05	Boston Scientific Scimed, Inc.	Chemoablation of tissue using biodegradable, solid salt dosage forms
AU2005208990A1 (en) *	2004-01-28	2005-08-11	Androscience Corporation	Enhancement of anti-androgenic activity by a combination of inhibitors targeting different steps of a steroid-dependent gene activation pathway and uses thereof
CA2577852A1 (en) *	2004-08-31	2006-03-09	Pfizer Products Inc.	Pharmaceutical dosage forms comprising a low-solubility drug and a polymer
GB0424339D0 (en) *	2004-11-03	2004-12-08	Astrazeneca Ab	Combination therapy
CN101128195A (zh) *	2005-02-23	2008-02-20	阿斯利康(瑞典)有限公司	用于递送增加的稳态血浆水平的比卡鲁胺
WO2006103689A1 (en) *	2005-03-29	2006-10-05	Usv Limited	Process for preparation of bicalutamide
US20090291134A1 (en) *	2006-11-21	2009-11-26	Jina Pharmaceuticals, Inc.	Endoxifen methods and compositions in the treatment of psychiatric and neurodegenerative diseases
EP2252893B1 (de) *	2008-02-21	2013-10-23	Iris International, Inc.	Verfahren zur frühen bestimmung des wiederauftretens nach einer therapie gegen prostatakrebs
CN102238941A (zh) *	2008-09-17	2011-11-09	迈兰实验室公司	颗粒、制备它们的方法和包含它们的药物产品
TWI673051B (zh)	2012-09-11	2019-10-01	美商梅維森前列腺療法有限責任公司	恩雜魯它脈（ｅｎｚａｌｕｔａｍｉｄｅ）之調和物
US12133911B2 (en)	2015-06-09	2024-11-05	Capsugel Belgium Nv	Formulations to achieve rapid dissolution of drug from spray-dried dispersions in capsules
CN107049972A (zh) *	2017-03-17	2017-08-18	万特制药(海南)有限公司	一种含有来曲唑固体分散体的分散片及其制备工艺

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3121152A1 (de) *	1981-05-22	1982-12-09	Schering Ag, 1000 Berlin Und 4619 Bergkamen	"verwendung der kombination eines aromatase-hemmers mit einem antiandrogen zur prophylaxe und therapie der prostatahyperplasie"
US4895715A (en) *	1988-04-14	1990-01-23	Schering Corporation	Method of treating gynecomastia
WO1995019770A1 (en) *	1994-01-21	1995-07-27	Sepracor, Inc.	Methods and compositions for treating androgen-dependent diseases using optically pure r-(-)-casodex
GB9707800D0 (en) *	1996-05-06	1997-06-04	Zeneca Ltd	Chemical compounds
US6139875A (en) *	1998-09-29	2000-10-31	Eastman Chemical Company	Aqueous enteric coating composition and low gastric permeability enteric coating

2001
- 2001-11-16 SE SE0103839A patent/SE0103839D0/xx unknown
2002
- 2002-10-31 TW TW091132270A patent/TW200406200A/zh unknown
- 2002-11-13 UY UY27539A patent/UY27539A1/es not_active Application Discontinuation
- 2002-11-14 AU AU2002343024A patent/AU2002343024A1/en not_active Abandoned
- 2002-11-14 CN CNA028272277A patent/CN1615122A/zh active Pending
- 2002-11-14 IL IL16190202A patent/IL161902A0/xx unknown
- 2002-11-14 WO PCT/GB2002/005159 patent/WO2003043606A1/en not_active Ceased
- 2002-11-14 MX MXPA04004591A patent/MXPA04004591A/es unknown
- 2002-11-14 EP EP02779684A patent/EP1448168B1/de not_active Expired - Lifetime
- 2002-11-14 KR KR1020047007359A patent/KR20050044468A/ko not_active Withdrawn
- 2002-11-14 US US10/495,012 patent/US20050038111A1/en not_active Abandoned
- 2002-11-14 CA CA002466986A patent/CA2466986A1/en not_active Abandoned
- 2002-11-14 BR BR0214135-3A patent/BR0214135A/pt not_active Application Discontinuation
- 2002-11-14 ES ES02779684T patent/ES2278063T3/es not_active Expired - Lifetime
- 2002-11-14 DE DE60217390T patent/DE60217390T2/de not_active Expired - Fee Related
- 2002-11-14 AT AT02779684T patent/ATE350016T1/de not_active IP Right Cessation
- 2002-11-14 AR ARP020104386A patent/AR037390A1/es unknown
- 2002-11-14 JP JP2003545287A patent/JP2005514355A/ja not_active Withdrawn
2004
- 2004-05-13 ZA ZA200403689A patent/ZA200403689B/en unknown
- 2004-06-15 NO NO20042502A patent/NO20042502L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
ZA200403689B (en)	2006-06-28
ATE350016T1 (de)	2007-01-15
SE0103839D0 (sv)	2001-11-16
MXPA04004591A (es)	2004-08-13
AR037390A1 (es)	2004-11-10
UY27539A1 (es)	2003-07-31
CN1615122A (zh)	2005-05-11
JP2005514355A (ja)	2005-05-19
WO2003043606A1 (en)	2003-05-30
CA2466986A1 (en)	2003-05-30
EP1448168B1 (de)	2007-01-03
DE60217390T2 (de)	2007-11-15
IL161902A0 (en)	2005-11-20
AU2002343024A1 (en)	2003-06-10
EP1448168A1 (de)	2004-08-25
US20050038111A1 (en)	2005-02-17
BR0214135A (pt)	2004-10-13
KR20050044468A (ko)	2005-05-12
ES2278063T3 (es)	2007-08-01
TW200406200A (en)	2004-05-01
DE60217390D1 (de)	2007-02-15

Legal Events

Date	Code	Title	Description
2006-07-03	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20033384D0 (no)	2003-07-29	Farmasöytisk formulering
NO20033785D0 (no)	2003-08-26	Farmasöytisk formulering
NO20033556L (no)	2003-10-09	Farmasöytiske formuleringer
FI20011478A0 (fi)	2001-07-05	Farmaseuttinen koostumus
NO20040125L (no)	2004-01-12	Enterale formuleringer
DK1395242T3 (da)	2006-10-30	Flydende farmaceutisk sammensætning
NO20035627D0 (no)	2003-12-15	Farmasöytisk formulering
EE200300589A (et)	2004-02-16	Ravimkoostised
FI20022128A7 (fi)	2003-06-06	Farmaseuttinen koostumus
IL161902A0 (en)	2005-11-20	Pharmaceutical formulation comprising bicalutamide
NO20041485L (no)	2004-04-13	Farmasoytisk formulering omfattende (R)-bicalutamid
DK1361791T3 (da)	2006-11-27	Agrokemisk formulering
ATE369137T1 (de)	2007-08-15	Lyophilisierte formulierung enthaltend olanzapin
DK1429753T3 (da)	2007-05-14	Farmaceutisk sammensætning omfattende gamma-butyrobetain
NO20015534D0 (no)	2001-11-12	Farmasöytisk blandeapparat
FI20012242A0 (fi)	2001-11-19	Uudet farmaseuttiset yhdisteet
NO20041236L (no)	2004-03-24	Farmasoytisk formulering
EP1413314A4 (de)	2004-12-22	Medizinische zusammensetzungen
SE0101325D0 (sv)	2001-04-12	Pharmaceutical formulation
SE0101171D0 (sv)	2001-04-02	Pharmaceutical formulation
SE0102572D0 (sv)	2001-07-19	Pharmaceutical formulation
SE0102957D0 (sv)	2001-09-04	Pharmaceutical formulation
SE0103565D0 (sv)	2001-10-25	Pharmaceutical formulation
SE0102069D0 (sv)	2001-06-21	Pharmaceutical formulation
SE0101326D0 (sv)	2001-04-12	Pharmaceutical formulation